Thorne Research Rhodiola rosea 60 () Supplement
Rhodiola rosea has been extensively studied in Russia and Scandinavian countries for over 35 years and is categorized as an adaptogen because of its ability to increase resistance to chemical, biological, and physical stressors. Rhodiola has been found to inhibit stress-induced depletion of catecholamines and facilitate the transport of neurotransmitters within the brain. The adaptogenic properties of Rhodiola have been attributed primarily to this ability to influence levels and activity of neurotransmitters and opioid peptides such as beta-endorphins. Because it is an adaptogen,Rhodiola has the potential to normalize neurotransmitters in the central nervous system without causing drowsiness or fatigue.Russian studies suggest a role for Rhodiola in situations characterized by a decline in work performance, poor appetite, sleep disturbances, irritability, headaches, and fatigue.